Free Trial

NewGenIvf Group (NIVF) Competitors

NewGenIvf Group logo
$0.56 -0.03 (-5.68%)
(As of 12:04 PM ET)

NIVF vs. OTRK, ATIP, MGRX, KDLY, ATPC, BGLC, VSEE, CMAX, ACON, and BACK

Should you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Ontrak (OTRK), ATI Physical Therapy (ATIP), Mangoceuticals (MGRX), Kindly MD (KDLY), Agape ATP (ATPC), BioNexus Gene Lab (BGLC), Vsee Health (VSEE), CareMax (CMAX), Aclarion (ACON), and IMAC (BACK). These companies are all part of the "healthcare" industry.

NewGenIvf Group vs.

NewGenIvf Group (NASDAQ:NIVF) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, community ranking, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

NewGenIvf Group has a beta of 0.2, indicating that its stock price is 80% less volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.59, indicating that its stock price is 159% more volatile than the S&P 500.

In the previous week, NewGenIvf Group had 4 more articles in the media than Ontrak. MarketBeat recorded 5 mentions for NewGenIvf Group and 1 mentions for Ontrak. NewGenIvf Group's average media sentiment score of 0.15 beat Ontrak's score of -0.58 indicating that NewGenIvf Group is being referred to more favorably in the media.

Company Overall Sentiment
NewGenIvf Group Neutral
Ontrak Negative

NewGenIvf Group has a net margin of 0.00% compared to Ontrak's net margin of -237.77%. NewGenIvf Group's return on equity of 0.00% beat Ontrak's return on equity.

Company Net Margins Return on Equity Return on Assets
NewGenIvf GroupN/A N/A N/A
Ontrak -237.77%-171.34%-113.42%

NewGenIvf Group has higher earnings, but lower revenue than Ontrak.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewGenIvf Group$5.14M0.41$130KN/AN/A
Ontrak$12.74M0.61-$27.92M-$10.62-0.17

Ontrak has a consensus price target of $45.00, suggesting a potential upside of 2,352.32%. Given Ontrak's stronger consensus rating and higher possible upside, analysts clearly believe Ontrak is more favorable than NewGenIvf Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NewGenIvf Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Ontrak
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Ontrak received 38 more outperform votes than NewGenIvf Group when rated by MarketBeat users.

CompanyUnderperformOutperform
NewGenIvf GroupN/AN/A
OntrakOutperform Votes
38
59.38%
Underperform Votes
26
40.63%

66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 13.0% of Ontrak shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by insiders. Comparatively, 1.9% of Ontrak shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

NewGenIvf Group beats Ontrak on 8 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NIVF vs. The Competition

MetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$2.09M$2.16B$5.09B$8.79B
Dividend YieldN/A7.23%5.04%4.07%
P/E RatioN/A11.4193.0914.02
Price / Sales0.416.101,220.6787.41
Price / Cash15.1410.1339.4936.27
Price / Book5.103.856.936.33
Net Income$130,000.00$69.56M$118.83M$225.71M
7 Day Performance-9.70%-2.24%-1.74%-0.58%
1 Month Performance-50.77%0.67%-3.60%1.49%
1 Year PerformanceN/A-19.41%31.91%27.23%

NewGenIvf Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NIVF
NewGenIvf Group
1.6259 of 5 stars
$0.56
-5.7%
N/AN/A$2.09M$5.14M0.00N/AGap Down
OTRK
Ontrak
2.7325 of 5 stars
$1.84
+0.3%
$45.00
+2,352.3%
-79.4%$7.74M$12.74M0.00250Gap Down
ATIP
ATI Physical Therapy
0.224 of 5 stars
$1.51
-5.3%
N/A-78.2%$6.64M$699.02M0.005,600
MGRX
Mangoceuticals
0.508 of 5 stars
$2.53
+2.4%
N/A-98.1%$6.30M$730,000.000.003Gap Down
KDLY
Kindly MD
0.1582 of 5 stars
$1.00
+9.5%
N/AN/A$5.96MN/A0.00N/AGap Up
ATPC
Agape ATP
0.013 of 5 stars
$1.47
+2.1%
N/A-92.4%$5.87M$1.43M0.0040
BGLC
BioNexus Gene Lab
N/A$0.29
-3.3%
N/A-22.6%$5.21M$9.77M0.0030
VSEE
Vsee Health
0.3541 of 5 stars
$1.31
-0.8%
N/AN/A$4.72MN/A0.00N/ANews Coverage
Gap Up
CMAX
CareMax
1.0108 of 5 stars
$0.83
+12.2%
N/A-97.4%$3.17M$751.10M0.001,450
ACON
Aclarion
2.6062 of 5 stars
$0.18
-0.2%
$1.50
+752.3%
-95.9%$1.84M$80,000.000.007News Coverage
Positive News
BACK
IMAC
N/A$1.02
-1.0%
N/A-29.9%$1.17M$16.19M0.00180

Related Companies and Tools


This page (NASDAQ:NIVF) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners